Lobbying registrant · LD-2 disclosures
Alexion Pharmaceuticals, Inc.
Massachusetts
45 filings · 1 client · 5 lobbyists registered · 2010–2021 · latest filed Oct 20, 2021
Fees billed to clients
$0
never billed a fee — files for itself
Its own lobbying spend
$11.8M
filed on its own behalf
Clients represented
1
5 lobbyists registered
Reported spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who they lobby for
This registrant files only on its own behalf — it has never reported a fee for representing anyone else.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee charged to a client.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR · 1 client
44 filings
$11.6M on those filings
Copyright/Patent/Trademark
CPT · 1 client
24 filings
$7.1M on those filings
Taxation/Internal Revenue Code
Who does the lobbying
Every lobbyist named on this registrant's filings.
- HEIDI L WAGNER esq34 filings1 client · through 2018
- Vanessa Procter31 filings1 client · through 2019
- Gregory KalbaughCovered position: International Trade Counsel, Senate Finance Committee, Repub15 filings1 client · through 2018
- Leigh Owano14 filings1 client · through 2019
- Katie Jones7 filings1 client · through 2021
Covered positions · 1 of 5 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
The filings
The 20 most recent of 45 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: alexion-pharmaceuticals-inc.